Evaluation the Pharmacokinetics, Safety, Tolerability of TK001 in Patients With Neovascular Age-related Macular Degeneration

NCT02613559 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Neovascular Age-related Macular Degeneration

Interventions

BIOLOGICAL: TK001

Sponsor

Jiangsu T-Mab Biopharma Co.,Ltd